The invention relates to the field of protein polypeptides and particularly relates to a small molecule polypeptide ERCP designed and prepared by a chemical synthesis or genetic engineering and protein engineering technology. The experimental results show that the polypeptide has tumor inhibiting effects of other angiogenesis inhibitors and can induce apoptosis in tumor cells. The small peptide isvery stable and may become a novel anti-tumor drug.